JP

Jeffrey Philip Poyser

AA Astrazeneca Ab: 8 patents #153 of 1,971Top 8%
IC ICI: 2 patents #677 of 2,189Top 35%
AL Astrazeneca Uk Limited: 1 patents #73 of 159Top 50%
📍 Wilmslow, GB: #7 of 95 inventorsTop 8%
Overall (All Time): #464,625 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
8710224 Heterocyclic compounds as CCR2B antagonists Justin Fairfield Bower, Paul F. Turner, David Waterson, Jon Winter 2014-04-29
7956084 Phenyl thiophene carboxamide compounds as inhibitors of the enzyme IKK-2 Alan Faull, Craig Johnstone, Andrew David Morley 2011-06-07
7943768 Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases Justin Fairfield Bower, Peter Wedderburn Kenny 2011-05-17
7906645 Heterocyclic compounds as ccr2b antagonists Justin Fairfield Bower, David Waterson 2011-03-15
7572826 Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 Alan Faull, Craig Johnstone, Andrew David Morley 2009-08-11
7553868 Thiophene carboxamides as inhibitors of the enzyme IKK-2 Andrew David Morley 2009-06-30
7498335 Method of producing an antiangiogenic or vascular permeability reducing effect Laurent Francois Andre Hennequin, Graham C. Crawley, Darren McKerrecher, Patrick Ple, Christine Marie Paul Lambert 2009-03-03
7001904 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases 2006-02-21
6806274 Quinazoline derivatives Graham C. Crawley, Laurent Francois Andre Hennequin, Darren McKerrecher, Patrick Ple, Christine Marie Paul Lambert 2004-10-19
5126444 Intermediates for cephalosporin compounds David G. Acton, David H. Davies 1992-06-30
5064824 Cephalosporin compounds David G. Acton, David H. Davies 1991-11-12